Here's how the therapy containing estrogen and progesterone initially got a bad rap—and what the research says about its potential benefits. Though a 2002 study led many to believe that hormone ...

Nov 24 (Reuters) - (This Nov 24 story has been corrected to fix the pricing for Zolgensma to $2.5 million from $2.1 million in paragraph 4) The U.S. Food and Drug Administration has approved Novartis' ...

On Monday, US Health and Human Services Secretary Robert F. Kennedy Jr. and US Food and Drug Administration Commissioner Dr. Marty Makary announced that after 20 years, they were righting a medical ...

Share on Pinterest The FDA will remove black box warning labels on HRT products, which the agency states has sown confusion around hormone therapy for menopause. Lupe Rodriguez/Stocksy The Food and ...

Journal Editorial Report: The week's best and worst from Kyle Peterson, Allysia Finley and Kim Strassel. Over the past two decades, tens of millions of women have been denied or not offered hormone ...

The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient. By Roni Caryn ...

"AI is transforming every enterprise, creating extraordinary opportunities and new risks. Prisma AIRS 2.0 bridges that gap, uniting deep model inspection, real-time agent defense, and continuous red ...

COLUMBIA, S.C. — Prisma Health has officially unveiled its new $128 million Northeast Medical Park, a new outpatient facility designed to bring expanded healthcare access to one of the Midlands’ ...

Women are at much greater risk of dementia than men—as many as two thirds of people in the US with Alzheimer’s disease are women—and likely for a mix of reasons that experts are still parsing out. One ...

Europe’s Pharmacovigilance Risk Assessment Committee (PRAC) has issued a new safety warning about the management of renal dialysis in critically ill patients receiving the antifungal agent caspofungin ...